Early innate responses to pathogens: Pattern recognition by unconventional human T-cells

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 31-37

  Liuzzi, Anna Rita ^a   McLaren, James E ^a   Price, David A ^a,b   Eberl, Matthias ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; GERMLINE ENCODED MYCOLYL REACTIVE T CELL; HUMAN; INFECTION; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MUCOSAL ASSOCIATED INVARIANT T CELL; T LYMPHOCYTE; VGAMMA9 VDELTA2 T CELL; ANIMAL; CYTOLOGY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PEYER PATCH; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; PEYER'S PATCHES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84937003209     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.06.002     Document Type: Review

References (60)

1. Lin C.Y., Roberts G.W., Kift-Morgan A., Donovan K.L., Topley N., Eberl M. Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J Am Soc Nephrol 2013, 24:2002-2009.
2. Oved K., Cohen A., Boico O., Navon R., Friedman T., Etshtein L., Kriger O., Bamberger E., Fonar Y., Yacobov R., et al. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS ONE 2015, 10:e0120012.
3. van Schaik B., Klarenbeek P., Doorenspleet M., van Kampen A., Moody D.B., de Vries N., Van Rhijn I. Discovery of invariant T cells by next-generation sequencing of the human TCR α-chain repertoire. J Immunol 2014, 193:5338-5344.
4. Willcox C.R., Pitard V., Netzer S., Couzi L., Salim M., Silberzahn T., Moreau J.F., Hayday A.C., Willcox B.E., Déchanet-Merville J. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012, 13:872-879.
5. Adams E.J. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. Curr Opin Immunol 2014, 26:1-6.
6. McEwen-Smith R.M., Salio M., Cerundolo V. CD1d-dependent endogenous and exogenous lipid antigen presentation. Curr Opin Immunol 2015, 34:116-125.
7. Davey M.S., Morgan M.P., Liuzzi A.R., Tyler C.J., Khan M.W., Szakmany T., Hall J.E., Moser B., Eberl M. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol 2014, 193:3704-3716.
8. Ussher J.E., Klenerman P., Willberg C.B. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol 2014, 5:450.
9. Tyler C.J., Doherty D.G., Moser B., Eberl M. Human Vγ9/Vδ2 T cells: innate adaptors of the immune system. Cell Immunol 2015, 296:10-21.
10. Davey M.S., Lin C.Y., Roberts G.W., Heuston S., Brown A.C., Chess J.A., Toleman M.A., Gahan C.G., Hill C., Parish T., et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog 2011, 7:e1002040.
11. Kjer-Nielsen L., Patel O., Corbett A.J., Le Nours J., Meehan B., Liu L., Bhati M., Chen Z., Kostenko L., Reantragoon R., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012, 491:717-723.
12. Van Rhijn I., Kasmar A., de Jong A., Gras S., Bhati M., Doorenspleet M.E., de Vries N., Godfrey D.I., Altman J.D., de Jager W., et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 2013, 14:706-713.
13. Mielke L.A., Jones S.A., Raverdeau M., Higgs R., Stefanska A., Groom J.R., Misiak A., Dungan L.S., Sutton C.E., Streubel G., et al. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med 2013, 210:1117-1124.
14. Fergusson J.R., Smith K.E., Fleming V.M., Rajoriya N., Newell E.W., Simmons R., Marchi E., Björkander S., Kang Y.H., Swadling L., et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 2014, 9:1075-1088.
15. Maher C.O., Dunne K., Comerford R., O'Dea S., Loy A., Woo J., Rogers T.R., Mulcahy F., Dunne P.J., Doherty D.G. Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vδ1 T cells. J Immunol 2015, 194:5953-5960.
16. Caccamo N., Dieli F., Wesch D., Jomaa H., Eberl M. Sex-specific phenotypical and functional differences in peripheral human Vγ9/Vδ2 T cells. J Leukoc Biol 2006, 79:663-666.
17. Novak J., Dobrovolny J., Novakova L., Kozak T. The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 2014, 80:271-275.
18. Leeansyah E., Loh L., Nixon D.F., Sandberg J.K. Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun 2014, 5:3143.
19. Dimova T., Brouwer M., Gosselin F., Tassignon J., Leo O., Donner C., Marchant A., Vermijlen D. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A 2015, 112:E556-E565.
20. Jing Y., Gravenstein S., Chaganty N.R., Chen N., Lyerly K.H., Joyce S., Deng Y. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol 2007, 42:719-732.
21. Chen C.Y., Yao S., Huang D., Wei H., Sicard H., Zeng G., Jomaa H., Larsen M.H., Jacobs W.R., Wang R., et al. Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog 2013, 9:e1003501.
22. Morita C.T., Jin C., Sarikonda G., Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007, 215:59-76.
23. Frencher J.T., Shen H., Yan L., Wilson J.O., Freitag N.E., Rizzo A.N., Chen C.Y., Chen Z.W. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol 2014, 96:957-967.
24. Workalemahu G., Wang H., Puan K.J., Nada M.H., Kuzuyama T., Jones B.D., Jin C., Morita C.T. Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. J Immunol 2014, 193:708-721.
25. Karunakaran M.M., Göbel T.W., Starick L., Walter L., Herrmann T. Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). Immunogenetics 2014, 66:243-254.
26. Harly C., Guillaume Y., Nedellec S., Peigné C.M., Mönkkönen H., Mönkkönen J., Li J., Kuball J., Adams E.J., Netzer S., et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood 2012, 120:2269-2279.
27. Vavassori S., Kumar A., Wan G.S., Ramanjaneyulu G.S., Cavallari M., El Daker S., Beddoe T., Theodossis A., Williams N.K., Gostick E., et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat Immunol 2013, 14:908-916.
28. + γδ T lymphocytes. Immunol Lett 2014, 161:133-137.
29. Sandstrom A., Peigné C.M., Léger A., Crooks J.E., Konczak F., Gesnel M.C., Breathnach R., Bonneville M., Scotet E., Adams E.J. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity 2014, 40:490-500.
30. Wang H., Henry O., Distefano M.D., Wang Y.C., Räikkönen J., Mönkkönen J., Tanaka Y., Morita C.T. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. J Immunol 2013, 191:1029-1042.
31. Hsiao C.H., Lin X., Barney R.J., Shippy R.R., Li J., Vinogradova O., Wiemer D.F., Wiemer A.J. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes. Chem Biol 2014, 21:945-954.
32. Rhodes D.A., Chen H.C., Price A.J., Keeble A.H., Davey M.S., James L.C., Eberl M., Trowsdale J. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. J Immunol 2015, 194:2390-2398.
33. Palakodeti A., Sandstrom A., Sundaresan L., Harly C., Nedellec S., Olive D., Scotet E., Bonneville M., Adams E.J. The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J Biol Chem 2012, 287:32780-32790.
34. Gold M.C., Eid T., Smyk-Pearson S., Eberling Y., Swarbrick G.M., Langley S.M., Streeter P.R., Lewinsohn D.A., Lewinsohn D.M. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol 2013, 6:35-44.
35. hi IL-17-secreting T cells. Blood 2011, 117:1250-1259.
36. Le Bourhis L., Martin E., Péguillet I., Guihot A., Froux N., Coré M., Lévy E., Dusseaux M., Meyssonnier V., Premel V., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010, 11:701-708.
37. Martin E., Treiner E., Duban L., Guerri L., Laude H., Toly C., Premel V., Devys A., Moura I.C., Tilloy F., et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009, 7:e54.
38. Wilson R.P., Ives M.L., Rao G., Lau A., Payne K., Kobayashi M., Arkwright P.D., Peake J., Wong M., Adelstein S., et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function. J Exp Med 2015, 212:855-864.
39. Lepore M., Kalinichenko A., Colone A., Paleja B., Singhal A., Tschumi A., Lee B., Poidinger M., Zolezzi F., Quagliata L., et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun 2014, 5:3866.
40. Huang S., Gilfillan S., Kim S., Thompson B., Wang X., Sant A.J., Fremont D.H., Lantz O., Hansen T.H. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med 2008, 205:1201-1211.
41. Patel O., Kjer-Nielsen L., Le Nours J., Eckle S.B., Birkinshaw R., Beddoe T., Corbett A.J., Liu L., Miles J.J., Meehan B., et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 2013, 4:2142.
42. Corbett A.J., Eckle S.B., Birkinshaw R.W., Liu L., Patel O., Mahony J., Chen Z., Reantragoon R., Meehan B., Cao H., et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 2014, 509:361-365.
43. Reantragoon R., Corbett A.J., Sakala I.G., Gherardin N.A., Furness J.B., Chen Z., Eckle S.B., Uldrich A.P., Birkinshaw R.W., Patel O., et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 2013, 210:2305-2320.
44. Gold M.C., McLaren J.E., Reistetter J.A., Smyk-Pearson S., Ladell K., Swarbrick G.M., Yu Y.Y., Hansen T.H., Lund O., Nielsen M., et al. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J Exp Med 2014, 211:1601-1610.
45. Reantragoon R., Kjer-Nielsen L., Patel O., Chen Z., Illing P.T., Bhati M., Kostenko L., Bharadwaj M., Meehan B., Hansen T.H., et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med 2012, 209:761-774.
46. López-Sagaseta J., Dulberger C.L., Crooks J.E., Parks C.D., Luoma A.M., McFedries A., Van Rhijn I., Saghatelian A., Adams E.J. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. Proc Natl Acad Sci U S A 2013, 110:E1771-E1778.
47. López-Sagaseta J., Dulberger C.L., McFedries A., Cushman M., Saghatelian A., Adams E.J. MAIT recognition of a stimulatory bacterial antigen bound to MR1. J Immunol 2013, 191:5268-5277.
48. Soudais C., Samassa F., Sarkis M., Le Bourhis L., Bessoles S., Blanot D., Hervé M., Schmidt F., Mengin-Lecreulx D., Lantz O. In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J Immunol 2015, 194:4641-4649.
49. Grimaldi D., Le Bourhis L., Sauneuf B., Dechartres A., Rousseau C., Ouaaz F., Milder M., Louis D., Chiche J.D., Mira J.P., et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 2014, 40:192-201.
50. Gold M.C., Cerri S., Smyk-Pearson S., Cansler M.E., Vogt T.M., Delepine J., Winata E., Swarbrick G.M., Chua W.J., Yu Y.Y., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010, 8:e1000407.
51. Kwon Y.S., Cho Y.N., Kim M.J., Jin H.M., Jung H.J., Kang J.H., Park K.J., Kim T.J., Kee H.J., Kim N., et al. Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity. Tuberculosis 2015, 95:267-274.
52. ++/MAIT cells in HIV infection. Blood 2013, 121:951-961.
53. Leeansyah E., Ganesh A., Quigley M.F., Sönnerborg A., Andersson J., Hunt P.W., Somsouk M., Deeks S.G., Martin J.N., Moll M., et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013, 121:1124-1135.
54. + mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics. PLoS ONE 2015, 10:e0117335.
55. Magalhaes I., Pingris K., Poitou C., Bessoles S., Venteclef N., Kiaf B., Beaudoin L., Da Silva J., Allatif O., Rossjohn J., et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 2015, 125:1752-1762.
56. Dunne M.R., Elliott L., Hussey S., Mahmud N., Kelly J., Doherty D.G., Feighery C.F. Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS ONE 2013, 8:e76008.
57. Layre E., de Jong A., Moody D.B. Human T cells use CD1 and MR1 to recognize lipids and small molecules. Curr Opin Chem Biol 2014, 23:31-38.
58. Montamat-Sicotte D.J., Millington K.A., Willcox C.R., Hingley-Wilson S., Hackforth S., Innes J., Kon O.M., Lammas D.A., Minnikin D.E., Besra G.S., et al. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 2011, 121:2493-2503.
59. Kasmar A.G., Van Rhijn I., Cheng T.Y., Turner M., Seshadri C., Schiefner A., Kalathur R.C., Annand J.W., de Jong A., Shires J., et al. CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 2011, 208:1741-1747.
60. Van Rhijn I., Gherardin N.A., Kasmar A., de Jager W., Pellicci D.G., Kostenko L., Tan L.L., Bhati M., Gras S., Godfrey D.I., et al. TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T cell repertoire. J Immunol 2014, 192:4054-4060.